Risk of metachronous neoplasia on surveillance colonoscopy in young patients with colorectal neoplasia
| Autor: | Kyeong Ok Kim, Jeong Eun Shin, Young-Seok Cho, Young-Eun Joo, Sun-Jin Boo, Hoon Sup Koo, Hyun Gun Kim, Jae Myung Cha, Hyo-Joon Yang |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty Adenoma Colon Colonoscopy Risk Assessment 03 medical and health sciences 0302 clinical medicine Older patients Risk Factors Internal medicine Republic of Korea medicine Humans Radiology Nuclear Medicine and imaging Family history Early Detection of Cancer Retrospective Studies medicine.diagnostic_test business.industry General surgery Incidence (epidemiology) Incidence Gastroenterology Rectum Retrospective cohort study Middle Aged medicine.disease 030220 oncology & carcinogenesis 030211 gastroenterology & hepatology Surveillance colonoscopy Female Baseline Colonoscopy business Colorectal Neoplasms |
| Zdroj: | Gastrointestinal endoscopy. 87(3) |
| ISSN: | 1097-6779 |
| Popis: | Few prior reports exist that address the appropriate colonoscopy surveillance interval for individuals 50 years old. We compared the risk of metachronous neoplasia between younger (20-49 years) and older (50-54 years) cohorts.This multicenter retrospective cohort study compared the incidence of metachronous neoplasia in younger and older cohorts according to baseline risk stratification. Subjects were eligible if they underwent their first colonoscopy between June 2006 and May 2010 and had at least 1 or more surveillance colonoscopy up to June 2015.Among a total of 10,477 subjects who underwent baseline colonoscopy, 9722 were eligible after excluding 755 subjects. Of those 9722 subjects, 43% underwent surveillance colonoscopy. In the baseline high-risk adenoma group (n = 840), the 3-year risk of metachronous advanced neoplasia was 10.7% in the younger patients on screening colonoscopy and 8.9% in the older patients (P.1). In the baseline low-risk adenoma group (n = 1869), the 5-year risk of metachronous advanced neoplasia was 4.9% in the younger patients on screening colonoscopy and 5.1% in the older patients (P.1). Similarly, in the baseline no neoplasia group (n = 7013), the 5-year risk of metachronous advanced neoplasia was 4.1% in the younger patients on screening colonoscopy and 5.6% in the older patients (P.1).Considering the similar risk of metachronous advanced neoplasia in younger and older individuals, we suggest a 3-year surveillance interval for high-risk adenoma and a 5-year surveillance interval for low-risk adenoma in young individuals without a strong family history. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect